ABVC BioPharma (ABVC) Competitors $3.39 -0.13 (-3.69%) As of 01:02 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ABVC vs. BNTC, HRTX, CTOR, IVA, VOR, CMPS, AVIR, AURA, RCKT, and GLUEShould you be buying ABVC BioPharma stock or one of its competitors? The main competitors of ABVC BioPharma include Benitec Biopharma (BNTC), Heron Therapeutics (HRTX), Citius Oncology (CTOR), Inventiva (IVA), Vor Biopharma (VOR), COMPASS Pathways (CMPS), Atea Pharmaceuticals (AVIR), Aura Biosciences (AURA), Rocket Pharmaceuticals (RCKT), and Monte Rosa Therapeutics (GLUE). These companies are all part of the "pharmaceutical products" industry. ABVC BioPharma vs. Its Competitors Benitec Biopharma Heron Therapeutics Citius Oncology Inventiva Vor Biopharma COMPASS Pathways Atea Pharmaceuticals Aura Biosciences Rocket Pharmaceuticals Monte Rosa Therapeutics Benitec Biopharma (NASDAQ:BNTC) and ABVC BioPharma (NASDAQ:ABVC) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings. Does the media refer more to BNTC or ABVC? In the previous week, ABVC BioPharma had 3 more articles in the media than Benitec Biopharma. MarketBeat recorded 5 mentions for ABVC BioPharma and 2 mentions for Benitec Biopharma. Benitec Biopharma's average media sentiment score of 0.47 beat ABVC BioPharma's score of 0.31 indicating that Benitec Biopharma is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Benitec Biopharma 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ABVC BioPharma 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is BNTC or ABVC more profitable? Benitec Biopharma has a net margin of 0.00% compared to ABVC BioPharma's net margin of -963.46%. ABVC BioPharma's return on equity of -29.62% beat Benitec Biopharma's return on equity.Company Net Margins Return on Equity Return on Assets Benitec BiopharmaN/A -38.26% -35.71% ABVC BioPharma -963.46%-29.62%-14.08% Do analysts recommend BNTC or ABVC? Benitec Biopharma currently has a consensus target price of $23.83, indicating a potential upside of 102.92%. Given Benitec Biopharma's stronger consensus rating and higher probable upside, equities research analysts clearly believe Benitec Biopharma is more favorable than ABVC BioPharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Benitec Biopharma 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.20ABVC BioPharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders believe in BNTC or ABVC? 52.2% of Benitec Biopharma shares are held by institutional investors. Comparatively, 11.4% of ABVC BioPharma shares are held by institutional investors. 1.3% of Benitec Biopharma shares are held by insiders. Comparatively, 17.1% of ABVC BioPharma shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has higher valuation & earnings, BNTC or ABVC? ABVC BioPharma has higher revenue and earnings than Benitec Biopharma. ABVC BioPharma is trading at a lower price-to-earnings ratio than Benitec Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBenitec Biopharma$80K3,853.83-$21.75M-$1.51-7.78ABVC BioPharma$510K112.87-$4.90M-$0.13-26.08 Which has more volatility and risk, BNTC or ABVC? Benitec Biopharma has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500. Comparatively, ABVC BioPharma has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500. SummaryBenitec Biopharma beats ABVC BioPharma on 9 of the 16 factors compared between the two stocks. Get ABVC BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ABVC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ABVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABVC vs. The Competition Export to ExcelMetricABVC BioPharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$57.56M$2.92B$5.51B$9.39BDividend YieldN/A2.46%4.25%4.09%P/E Ratio-26.0820.5428.2719.87Price / Sales112.87258.87424.8998.56Price / CashN/A42.3835.5357.53Price / Book56.507.768.215.70Net Income-$4.90M-$55.11M$3.24B$257.71M7 Day Performance1.19%1.94%0.43%0.89%1 Month Performance69.50%12.55%7.84%11.09%1 Year Performance264.52%0.64%28.19%16.58% ABVC BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABVCABVC BioPharma0.3812 of 5 stars$3.39-3.7%N/A+345.5%$57.56M$510K-26.0830News CoverageBNTCBenitec Biopharma1.5968 of 5 stars$12.92-4.2%$23.83+84.5%+12.9%$339.15M$80K-8.5620HRTXHeron Therapeutics3.5422 of 5 stars$2.22+3.3%$5.00+125.2%-45.0%$338.69M$148.52M-37.00300CTORCitius Oncology1.6285 of 5 stars$4.70-0.2%$3.00-36.2%N/A$336.29MN/A0.00N/AIVAInventiva3.1733 of 5 stars$3.50+15.9%$10.40+197.1%+32.3%$334.81M$9.95M0.00100Gap DownVORVor Biopharma3.5227 of 5 stars$2.66-0.6%$5.63+112.0%+109.9%$331.77MN/A-1.61140High Trading VolumeCMPSCOMPASS Pathways1.8051 of 5 stars$3.49+5.4%$17.00+387.1%-48.8%$326.52MN/A-1.75120Analyst ForecastAnalyst RevisionAVIRAtea Pharmaceuticals2.7481 of 5 stars$3.72+2.2%$6.00+61.3%-9.1%$318.36MN/A-2.2570Positive NewsAURAAura Biosciences2.5827 of 5 stars$6.27+1.8%$22.00+250.9%-24.9%$315.19MN/A-3.3050RCKTRocket Pharmaceuticals4.8501 of 5 stars$2.94+4.6%$18.60+532.7%-87.8%$313.96MN/A-1.12240Trending NewsGap UpGLUEMonte Rosa Therapeutics2.1808 of 5 stars$5.10+2.6%$15.33+200.7%+15.2%$313.70M$75.62M63.7690News CoveragePositive News Related Companies and Tools Related Companies Benitec Biopharma Competitors Heron Therapeutics Competitors Citius Oncology Competitors Inventiva Competitors Vor Biopharma Competitors COMPASS Pathways Competitors Atea Pharmaceuticals Competitors Aura Biosciences Competitors Rocket Pharmaceuticals Competitors Monte Rosa Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ABVC) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ABVC BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ABVC BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABVC Stock Alerts